ERBB2 and cancer: After estimating relative cellular phenotype abundances from bulk RNA sequencing, we found cancer-associated fibroblasts more abundant in HR + HER2− tumors, particularly higher in immune-high HR + HER2− tumors than immune-high TN tumors, while helper T cell populations were more abundant in immune-high TN tumors.